Skip to main content
. 2022 Jul 13;28:1610360. doi: 10.3389/pore.2022.1610360

FIGURE 1.

FIGURE 1

Landscape of ERBB2 alterations. (A) Landscape of ERBB2 amplifications and ERBB2 mutations across different tumor types. (B) Prevalence of the pathogenic or very likely pathogenic somatic mutations of ERBB2 in furin-like region, transmembrane domain, and tyrosine kinase domain. (C) ERBB2 somatic mutation map.